Rationale for further clinical trials with 6-diazo-5-oxo-L-norleucine (DON)

R. Catane, A. A. Ovejera, D. P. Houchens

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)No.C-41
JournalProceedings of the American Association for Cancer Research
VolumeVol. 19
StatePublished - 1978
Externally publishedYes

Cite this